Open access · OA
via Europe PMC
Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging.
Joshi D, Rafiq T, Pigeyre M, de Mutsert R, Rutters F, Campbell DJT, Despres JP, Carpentier AC, Hoeks J, Schrauwen P, Raina P.
Diabetes, obesity & metabolism · 2026
Abstract
<h4>Aims</h4>Circadian regulation of metabolism is an important factor in metabolic health, yet the role of rhythmic metabolites in Type 2 diabetes development remains poorly understood. This study investigated associations between circulating rhythmic metabolites and incident Type 2 diabetes risk and evaluated causal relationships using two-sample Mendelian randomisation.<h4>Materials and methods</h4>We analysed longitudinal data from 9992 community-dwelling adults aged 45-85 years (49.1% male) in the Canadian Longitudinal Study on Aging with baseline (2012-2015) serum metabolomics data. Untargeted metabolomics profiling was conducted using ultrahigh-performance liquid chromatography-tandem mass spectrometry. Incident Type 2 diabetes at 3-year follow-up was assessed based on diabetes medication use and HbA1c level. Associations between rhythmic metabolites and diabetes risk were evaluated using multivariable binomial regression. Pathway and network analyses were conducted to explore underlying biological mechanisms. Causality was assessed using two-sample Mendelian randomisation for rhythmic metabolites significantly associated with diabetes risk.<h4>Results</h4>Altogether, 20 rhythmic metabolites were associated with Type 2 diabetes risk, including a subset overlapping with genetic predisposition to chronotype, suggesting potential circadian regulation. Key pathways included leucine, isoleucine and valine biosynthesis and degradation, and glycine, serine and threonine metabolism. Mendelian randomisation analyses revealed causal associations between higher levels of mannose, valine, isoleucine, threonine and sphingomyelin (d18:0/18:0, d19:0/17:0) and higher Type 2 diabetes risk, whereas creatine, glycine, 1-linoleoyl-GPC (18:2), 1-palmitoyl-2-oleoyl-GPE, 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) and 1-stearoyl-2-oleoyl-GPE (18:0/18:1) were protective.<h4>Conclusions</h4>Disruptions in rhythmic metabolites are implicated in Type 2 diabetes pathophysiology through specific metabolic pathways, highlighting the potential for biomarkers to support circadian-based prevention strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/dom.70616
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
D, J., T, R., M, P., R, D.M., F, R., DJT, C., JP, D., AC, C., J, H., P, S., & P., R. (2026). Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging. <em>Diabetes, obesity & metabolism</em>. https://doi.org/10.1111/dom.70616
Vancouver
D J, T R, M P, R DM, F R, DJT C, et al. Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging. Diabetes, obesity & metabolism. 2026. doi:10.1111/dom.70616.
BibTeX
@article{joshi2026Circul,
title = {Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging.},
author = {Joshi D and Rafiq T and Pigeyre M and de Mutsert R and Rutters F and Campbell DJT and Despres JP and Carpentier AC and Hoeks J and Schrauwen P and Raina P.},
journal = {Diabetes, obesity & metabolism},
year = {2026},
doi = {10.1111/dom.70616},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2026
Preprint · CC-BY
Accelerated hematopoietic aging in type 1 diabetes links telomere attrition to myocardial infarction
Diabetes Care 2022
Open access · OA
An Examination of Whether Diabetes Control and Treatments Are Associated With Change in Frailty Index Across 8 Years: An Ancillary Exploratory Study From the Action for Health in Diabetes (Look AHEAD) Trial
GeroScience 2024
Open access · CC-BY
Associations between epigenetic aging and diabetes mellitus in a Swedish longitudinal study
2022
Open access · CC-BY
An examination of whether diabetes control and treatments are associated with change in frailty index across 8 Years. An ancillary exploratory study from the Action for Health in Diabetes (Look AHEAD) Trial
2022
Open access · CC-BY
An examination of whether diabetes control and treatments are associated with change in frailty index across 8 Years. An ancillary exploratory study from the Action for Health in Diabetes (Look AHEAD) Trial
Cyborg and bionic systems (Washington, D.C.) 2026
Open access · OA